San Francisco Bay Area biotech stories.
Friday, August 10, 2012
Adynxx glimpses gain from no-pain drugs
Adynxx's Julien Mamet and Rick Orr.
A team that built and sold three Bay Area drug companies over the past decade is looking for a fourth
. But the latest venture, called Adynxx Inc., could be a big pain. The young San Francisco company is entering its first human trial of a treatment to prevent post-surgical pain and, ultimately, chronic pain.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)